Hari Anant Deshpande MD
Assistant Professor of Medicine (Medical Oncology) and of Surgery (Otolaryngology) and Assistant Clinical Professor of Nursing
Clinical Interests
Head and neck cancer; Genitourinary (GU) cancers; sarcomas; thyroid cancer.
Board Certifications
- 1998
- Hematology, Internal Medicine, Board Certified
- 1995
- Internal Medicine, Board Certified
- 1999
- Medical Oncology, Board Certified
Patient Care Locations
hari_deshpandefaculty-clinicsfalsetruefalse
Clinical Trials
| Conditions | Study Title |
|---|---|
| Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer, and Distal Urethral Cancer | Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer |
| Head and Neck Cancer | A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer (ECOG E1305) |



